Bottom line
PPH vs SCHLX: the short answer
PPH (VanEck Pharmaceutical ETF) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 50% by weight.
But SCHLX is far broader, holding 65 positions to 26 for PPH, so beyond the top names it adds exposure PPH doesn't have.
PPH is cheaper at 0.36% vs 1.06% — a difference of $70 a year per $10,000 invested.
Updated Nov 19, 2026
PPH vs SCHLX side by side
| PPH | SCHLX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | VanEck | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.36% | 1.06% |
| Annual cost per $10k | $36 | $106 |
| 10-yr cost on $10k (prospectus) | $456 | $1,294 |
| Max front load | None | 0% |
| 12b-1 fee | — | 0% |
| 1-yr return | +21.9% | — |
| 5-yr return (annualized) | +11.3% | — |
| 10-yr return (annualized) | +6.7% | — |
| Best quarter | +16.5% | — |
| Worst quarter | −15.0% | — |
| Net assets (fund) | $879.5M | $231.8M |
| Number of holdings | 26 | 65 |
| Portfolio turnover | 3% | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
11 of PPH's top 25 holdings also appear in SCHLX's top 25.
| Holding | PPH | SCHLX |
|---|---|---|
| Eli Lilly & Co | 20.23% | 13.85% |
| Novartis AG | 10.63% | 2.90% |
| Merck & Co Inc | 9.85% | 4.85% |
| Novo Nordisk A/S | 5.37% | 1.73% |
| AbbVie Inc | 4.57% | 4.90% |
| Pfizer Inc | 4.51% | 1.17% |
| Bristol-Myers Squibb Co | 4.47% | 1.50% |
| Johnson & Johnson | 4.35% | 6.19% |
| AstraZeneca PLC | 4.33% | 3.80% |
| McKesson Corp | 4.12% | 2.05% |
| Cencora Inc | 3.36% | 1.26% |
Source: SEC Form N-PORT
PPH top 10
- Eli Lilly & Co — 20.23%
- Novartis AG — 10.63%
- Merck & Co Inc — 9.85%
- Novo Nordisk A/S — 5.37%
- AbbVie Inc — 4.57%
- Pfizer Inc — 4.51%
- Bristol-Myers Squibb Co — 4.47%
- Gsk Plc — 4.42%
- Johnson & Johnson — 4.35%
- AstraZeneca PLC — 4.33%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between PPH and SCHLX?
Which is cheaper, PPH or SCHLX?
Should I own both PPH and SCHLX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.